Published in Prim Care Companion CNS Disord on November 29, 2012
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care (1992) 144.02
Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist (1969) 45.63
Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ (1992) 26.37
PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care (2001) 18.55
Psychometric properties of the strengths and difficulties questionnaire. J Am Acad Child Adolesc Psychiatry (2001) 15.43
The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry (2006) 11.85
The PedsQL: measurement model for the pediatric quality of life inventory. Med Care (1999) 11.09
Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2007) 6.57
Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics (2001) 5.30
Behavior rating inventory of executive function. Child Neuropsychol (2000) 4.87
Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry (2000) 4.34
The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry (1993) 3.59
Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children --- United States, 2003 and 2007. MMWR Morb Mortal Wkly Rep (2010) 3.54
A practical measure of impairment: psychometric properties of the impairment rating scale in samples of children with attention deficit hyperactivity disorder and two school-based samples. J Clin Child Adolesc Psychol (2006) 3.46
Evidence-based assessment of attention deficit hyperactivity disorder in children and adolescents. J Clin Child Adolesc Psychol (2005) 3.39
Categorical and Dimensional Definitions and Evaluations of Symptoms of ADHD: History of the SNAP and the SWAN Rating Scales. Int J Educ Psychol Assess (2012) 3.15
Impaired but undiagnosed. J Am Acad Child Adolesc Psychiatry (1999) 2.64
European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry (2010) 2.53
Functional impairments in adults with self-reports of diagnosed ADHD: A controlled study of 1001 adults in the community. J Clin Psychiatry (2006) 2.48
The quality of life of children with attention deficit/hyperactivity disorder: a systematic review. Eur Child Adolesc Psychiatry (2009) 2.47
Long-term school outcomes for children with attention-deficit/hyperactivity disorder: a population-based perspective. J Dev Behav Pediatr (2007) 2.36
Ten-year review of rating scales. V: scales assessing attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2003) 2.34
Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder. Pediatrics (2004) 2.25
Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers. J Dev Behav Pediatr (2001) 2.20
Neuropsychology of adults with attention-deficit/hyperactivity disorder: a meta-analytic review. Neuropsychology (2004) 2.12
Preschool children with attention-deficit/hyperactivity disorder: impairments in behavioral, social, and school functioning. J Am Acad Child Adolesc Psychiatry (2001) 2.10
Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behav Res Ther (2005) 2.08
Parent and teacher SNAP-IV ratings of attention deficit hyperactivity disorder symptoms: psychometric properties and normative ratings from a school district sample. Assessment (2008) 2.05
Efficacy of methylphenidate, psychosocial treatments and their combination in school-aged children with ADHD: a meta-analysis. Clin Psychol Rev (2007) 1.99
Validity of the World Health Organization Adult ADHD Self-Report Scale (ASRS) Screener in a representative sample of health plan members. Int J Methods Psychiatr Res (2007) 1.87
Development of a brief coping checklist for use with pediatric populations. J Pediatr Psychol (1988) 1.85
A meta-analysis of behavioral treatments for attention-deficit/hyperactivity disorder. Clin Psychol Rev (2008) 1.78
Genetics of childhood disorders: XVII. ADHD, Part 1: The executive functions and ADHD. J Am Acad Child Adolesc Psychiatry (2000) 1.70
Structure and diagnosis of adult attention-deficit/hyperactivity disorder: analysis of expanded symptom criteria from the Adult ADHD Clinical Diagnostic Scale. Arch Gen Psychiatry (2010) 1.68
Neuropsychological functioning in people with ADHD across the lifespan. Clin Psychol Rev (2006) 1.66
A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. J Clin Psychiatry (2009) 1.66
Confirmatory factor analysis of the Behavior Rating Inventory of Executive Function (BRIEF) in a clinical sample. Child Neuropsychol (2002) 1.58
Executive functioning in adult ADHD: a meta-analytic review. Psychol Med (2005) 1.57
Effects of atomoxetine with and without behavior therapy on the school and home functioning of children with attention-deficit/hyperactivity disorder. J Clin Psychiatry (2010) 1.56
Impact of psychometrically defined deficits of executive functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry (2006) 1.55
Executive functions: performance-based measures and the behavior rating inventory of executive function (BRIEF) in adolescents with attention deficit/hyperactivity disorder (ADHD). Child Neuropsychol (2009) 1.45
A cognitive remediation programme for adults with Attention Deficit Hyperactivity Disorder. Aust N Z J Psychiatry (2002) 1.43
Self-perceptions of competence in children with ADHD and comparison children. J Consult Clin Psychol (2004) 1.43
The marital and family functioning of adults with ADHD and their spouses. J Atten Disord (2004) 1.40
Endicott Work Productivity Scale (EWPS): a new measure to assess treatment effects. Psychopharmacol Bull (1997) 1.39
Concordance of self- and informant ratings of adults' current and childhood attention-deficit/hyperactivity disorder symptoms. Psychol Assess (2002) 1.37
The Child Report Form of the CHIP-Child Edition: reliability and validity. Med Care (2004) 1.36
Using Meta-analysis to Compare the Efficacy of Medications for Attention-Deficit/Hyperactivity Disorder in Youths. P T (2009) 1.36
Diagnostic uses of the Vineland Adaptive Behavior Scales. J Pediatr Psychol (1985) 1.36
Reliability and validity of the SKAMP rating scale in a laboratory school setting. Psychopharmacol Bull (1998) 1.30
Attention-deficit/hyperactivity disorder outcomes for children treated in community-based pediatric settings. Arch Pediatr Adolesc Med (2010) 1.30
Executive function profile of children with attention deficit hyperactivity disorder. Dev Neuropsychol (2002) 1.29
Adaptive skills dysfunction in ADD and ADHD children. J Child Psychol Psychiatry (1995) 1.21
Cognitive behaviour therapy in medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. BMC Psychiatry (2011) 1.19
The reliability and validity of the English and Spanish Strengths and Weaknesses of ADHD and Normal behavior rating scales in a preschool sample: continuum measures of hyperactivity and inattention. J Atten Disord (2011) 1.19
Atomoxetine treatment in children and adolescents with attention-deficit hyperactivity disorder: what are the long-term health-related quality-of-life outcomes? J Child Adolesc Psychopharmacol (2006) 1.17
Validation of the adult attention-deficit/hyperactivity disorder quality-of-life Scale (AAQoL): a disease-specific quality-of-life measure. Qual Life Res (2006) 1.17
Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis. Psychopharmacology (Berl) (2007) 1.12
Psychometric validation of the child health questionnaire (CHQ) in a sample of children and adolescents with attention-deficit/hyperactivity disorder. Qual Life Res (2005) 1.11
Methylphenidate improves visual-spatial memory in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2004) 1.10
Executive function in adolescents with ADHD. J Am Acad Child Adolesc Psychiatry (2007) 1.09
Stability of executive function deficits into young adult years: a prospective longitudinal follow-up study of grown up males with ADHD. Acta Psychiatr Scand (2007) 1.08
Effects of stimulant medication on neuropsychological functioning in young adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry (2008) 1.07
Current status of cognitive behavioral therapy for adult attention-deficit hyperactivity disorder. Psychiatr Clin North Am (2010) 1.06
Measuring quality of life in children with attention-deficit/hyperactivity disorder and their families: development and evaluation of a new tool. Arch Pediatr Adolesc Med (2002) 1.05
The reliability and validity of self- and investigator ratings of ADHD in adults. J Atten Disord (2007) 1.05
Validity of the health-related quality of life assessment in the ADORE study: Parent Report Form of the CHIP-Child Edition. Eur Child Adolesc Psychiatry (2006) 1.05
Social functioning in predominantly inattentive and combined subtypes of children with ADHD. J Atten Disord (2009) 1.03
Treating attention-deficit/hyperactivity disorder beyond symptom control alone in children and adolescents: a review of the potential benefits of long-acting stimulants. Eur Child Adolesc Psychiatry (2009) 1.01
Deficient emotional self-regulation and adult attention deficit hyperactivity disorder: a family risk analysis. Am J Psychiatry (2011) 1.01
Improvements in executive function correlate with enhanced performance and functioning and health-related quality of life: evidence from 2 large, double-blind, randomized, placebo-controlled trials in ADHD. Postgrad Med (2010) 1.00
Developmental processes in peer problems of children with attention-deficit/hyperactivity disorder in the Multimodal Treatment Study of Children With ADHD: developmental cascades and vicious cycles. Dev Psychopathol (2010) 1.00
Atomoxetine in the management of children with ADHD: effects on quality of life and school functioning. Clin Pediatr (Phila) (2006) 0.99
Responsiveness of the Adult Attention-Deficit/Hyperactivity Disorder Quality of Life Scale (AAQoL). Qual Life Res (2007) 0.99
Evaluation of group cognitive behavioral therapy for adults with ADHD. J Atten Disord (2008) 0.97
Triple-bead mixed amphetamine salts (SPD465), a novel, enhanced extended-release amphetamine formulation for the treatment of adults with ADHD: a randomized, double-blind, multicenter, placebo-controlled study. J Clin Psychiatry (2008) 0.97
Functional outcomes in the treatment of adults with ADHD. J Atten Disord (2007) 0.96
Quality of life of adolescent males with attention-deficit hyperactivity disorder. J Atten Disord (2004) 0.95
Effects of methylphenidate on working memory components: influence of measurement. J Child Psychol Psychiatry (2007) 0.92
Self-reported ADHD and adjustment in college: cross-sectional and longitudinal findings. J Atten Disord (2009) 0.92
Cross-informant agreement for ratings for social skill and problem behavior ratings: an investigation of the Social Skills Improvement System-Rating Scales. Psychol Assess (2010) 0.92
Adaptive functioning in children with attention-deficit hyperactivity disorder. Arch Pediatr Adolesc Med (1994) 0.92
The Life Participation Scale for Attention-Deficit/Hyperactivity Disorder--Child Version: psychometric properties of an adaptive change instrument. J Child Adolesc Psychopharmacol (2007) 0.92
A meta-analysis of combined treatments for children diagnosed with ADHD. J Atten Disord (2007) 0.91
Monitoring quality of life in adults with ADHD: reliability and validity of a new measure. J Atten Disord (2007) 0.89
Executive functioning among Finnish adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2007) 0.89
Effectiveness outcomes in attention-deficit/hyperactivity disorder. J Clin Psychiatry (2006) 0.88
ADD/ADHD and Impaired Executive Function in Clinical Practice. Curr Psychiatry Rep (2008) 0.88
Moderators and mediators of symptoms and quality of life outcomes in an open-label study of adults treated for attention-deficit/hyperactivity disorder. J Clin Psychiatry (2010) 0.88
Multiscale assessment of treatment efficacy in adults with ADHD: a randomized placebo-controlled, multi-centre study with extended-release methylphenidate. World J Biol Psychiatry (2010) 0.88
Effects of atomoxetine on self-reported high-risk behaviors and health-related quality of life in adolescents with ADHD. Curr Med Res Opin (2010) 0.88
Relationship of attention-deficit-hyperactivity disorder symptoms, depressive/anxiety symptoms, and life quality in young men. Psychiatry Clin Neurosci (2008) 0.88
Anxiety, methylphenidate response, and working memory in children with ADHD. J Atten Disord (2007) 0.87
Short cognitive behavioral therapy and cognitive training for adults with ADHD - a randomized controlled pilot study. Neuropsychiatr Dis Treat (2010) 0.84
Open-label administration of lisdexamfetamine dimesylate improves executive function impairments and symptoms of attention-deficit/hyperactivity disorder in adults. Postgrad Med (2010) 0.84
Therapy-relevant factors in adult ADHD from a cognitive behavioural perspective. Atten Defic Hyperact Disord (2010) 0.83
A controlled trial of the methylphenidate transdermal system on before-school functioning in children with attention-deficit/hyperactivity disorder. J Clin Psychiatry (2010) 0.83
Can parent reports serve as a proxy for teacher ratings in medication management of attention-deficit hyperactivity disorder? J Dev Behav Pediatr (2012) 0.83
Item response theory analyses of adult self-ratings of the ADHD symptoms in the Current Symptoms Scale. Assessment (2010) 0.82
Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. Drug Alcohol Depend (2008) 1.21
Clinical responses to atomoxetine in attention-deficit/hyperactivity disorder: the Integrated Data Exploratory Analysis (IDEA) study. J Am Acad Child Adolesc Psychiatry (2009) 1.14
A randomized, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities. J Pineal Res (2008) 1.14
International variation in treatment procedures for ADHD: social context and recent trends. Psychiatr Serv (2011) 1.07
Sleep hygiene for children with neurodevelopmental disabilities. Pediatrics (2008) 0.97
Psychiatric comorbidity in ADHD symptom subtypes in clinic and community adults. J Atten Disord (2007) 0.94
Time courses of improvement and symptom remission in children treated with atomoxetine for attention-deficit/hyperactivity disorder: analysis of Canadian open-label studies. Child Adolesc Psychiatry Ment Health (2011) 0.92
High-dose atomoxetine treatment of ADHD in youths with limited response to standard doses. J Am Acad Child Adolesc Psychiatry (2007) 0.88
Long-term effectiveness outcome of melatonin therapy in children with treatment-resistant circadian rhythm sleep disorders. J Pineal Res (2007) 0.86
New developments in the treatment of ADHD. J Clin Psychiatry (2006) 0.84
Evidence for a general factor model of ADHD in adults. J Atten Disord (2011) 0.84
Nutritional status of children with attention deficit hyperactivity disorder: a pilot study. Int J Pediatr (2010) 0.82
Turkish validity and reliability study of the Weiss Functional Impairment Rating Scale-Parent Report. Atten Defic Hyperact Disord (2014) 0.82
ODD, ADHD, versus ODD+ADHD in clinic and community adults. J Atten Disord (2007) 0.80
The effects of instructions on mothers' ratings of attention-deficit/hyperactivity disorder symptoms in referred children. J Abnorm Child Psychol (2014) 0.78
The soft underbelly of research in the psychosocial treatment of ADHD. J Atten Disord (2009) 0.75